2. Academic Validation
  3. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease

Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease

  • Cell. 2018 Oct 4;175(2):372-386.e17. doi: 10.1016/j.cell.2018.08.067.
James Kinchen 1,  Hannah H Chen 1,  Kaushal Parikh 1,  Agne Antanaviciute 2,  Marta Jagielowicz 1,  David Fawkner-Corbett 1,  Neil Ashley 3,  Laura Cubitt 4,  Esther Mellado-Gomez 4,  Moustafa Attar 4,  Eshita Sharma 4,  Quin Wills 5,  Rory Bowden 4,  Felix C Richter 6,  David Ahern 6,  Kamal D Puri 7,  Jill Henault 8,  Francois Gervais 8,  Hashem Koohy 9,  Alison Simmons 10
Affiliations

Affiliations

  • 1 MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.
  • 2 MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK; MRC WIMM Centre For Computational Biology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
  • 3 Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
  • 4 Wellcome Trust Centre for Human Genetics, University of Oxford, Headington, Oxford OX3 7BN, UK.
  • 5 Novo Nordisk Research Centre Oxford, Oxford, UK.
  • 6 Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • 7 OncoResponse, Inc., Seattle, WA 98104, USA.
  • 8 Translational Development, Celgene Corporation, Cambridge, MA, USA.
  • 9 MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; MRC WIMM Centre For Computational Biology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
  • 10 MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK. Electronic address: alison.simmons@imm.ox.ac.uk.
PMID: 30270042 DOI: 10.1016/j.cell.2018.08.067
Abstract

Intestinal mesenchymal cells play essential roles in epithelial homeostasis, matrix remodeling, immunity, and inflammation. But the extent of heterogeneity within the colonic mesenchyme in these processes remains unknown. Using unbiased single-cell profiling of over 16,500 colonic mesenchymal cells, we reveal four subsets of fibroblasts expressing divergent transcriptional regulators and functional pathways, in addition to pericytes and myofibroblasts. We identified a niche population located in proximity to epithelial crypts expressing SOX6, F3 (CD142), and Wnt genes essential for colonic epithelial stem cell function. In colitis, we observed dysregulation of this niche and emergence of an activated mesenchymal population. This subset expressed TNF Superfamily member 14 (TNFSF14), fibroblastic reticular cell-associated genes, IL-33, and Lysyl oxidases. Further, it induced factors that impaired epithelial proliferation and maturation and contributed to oxidative stress and disease severity in vivo. Our work defines how the colonic mesenchyme remodels to fuel inflammation and barrier dysfunction in IBD.

Keywords

CyTOF; SOX6; TNFSF14; Wnts; crypt niche; inflammatory bowel disease; mesenchyme; single-cell RNA-seq; stratification; stromal cell; target discovery.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z